Enanta Pharmaceuticals
ENTA
ENTA
176 hedge funds and large institutions have $1.08B invested in Enanta Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 81 increasing their positions, 54 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
176
Holders Change
-18
Holders Change %
-9.28%
% of All Funds
3.87%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
13
Increased
81
Reduced
54
Closed
31
Calls
$5.22M
Puts
$7.2M
Net Calls
-$1.99M
Net Calls Change
+$5.67M
Top Buyers
| 1 |
FCM
1
Farallon Capital Management
San Francisco,
California
|
$76.6M |
| 2 |
AC
2
Armistice Capital
New York
|
$34.8M |
| 3 |
3
Man Group
London,
United Kingdom
|
$17.8M |
| 4 |
4
Renaissance Technologies
New York
|
$39.8M |
| 5 |
5
Goldman Sachs
New York
|
$16.4M |
Top Sellers
| 1 |
1
Ameriprise
Minneapolis,
Minnesota
|
$6.49M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$5.45M |
| 3 |
3
First Manhattan
New York
|
$30.6M |
| 4 |
4
Janus Henderson Group
London,
United Kingdom
|
$52M |
| 5 |
5
Fidelity Investments
Boston,
Massachusetts
|
$4.79M |
